8-K: AXT Reports Strong Q3 2025 Indium Phosphide Growth
Quarterly Report
AXT, Inc. announced its third quarter 2025 financial results, highlighted by a significant sequential increase in indium phosphide revenue and improved gross margins.
Summary
- Revenue for the third quarter of 2025 was $28.0 million, a significant increase from $18.0 million in Q2 2025 and $23.6 million in Q3 2024.
- Indium phosphide revenues grew more than 250 percent sequentially, reaching a three-year high due to obtaining export permits for significant orders.
- GAAP gross margin improved to 22.3 percent of revenue in Q3 2025, compared with 8.0 percent in Q2 2025 and 24.0 percent in Q3 2024.
- Non-GAAP gross margin was 22.4 percent of revenue in Q3 2025, up from 8.2 percent in Q2 2025 and compared to 24.3 percent in Q3 2024.
- GAAP net loss for Q3 2025 was $1.9 million, or $0.04 per share, a substantial improvement from a net loss of $7.0 million, or $0.16 per share, in Q2 2025.
- Non-GAAP net loss for Q3 2025 was $1.2 million, or $0.03 per share, compared with a net loss of $6.4 million, or $0.15 per share, in Q2 2025.
- The company is building healthy backlog for both indium phosphide and gallium arsenide materials.
- The STAR Market IPO application for its subsidiary, Tongmei, remains subject to review and approval by the CSRC and other authorities, with the company hoping to accomplish this goal in the coming months.
Sentiment
Score: 7
Explanation: While still reporting a net loss, the significant sequential improvements in revenue, gross margin, and net loss, driven by strong indium phosphide demand, indicate a positive operational turnaround and strong future outlook. The ongoing STAR Market IPO process is a positive long-term catalyst, despite its lengthy nature.
Positives
- Indium phosphide revenue grew over 250% sequentially, reaching a three-year high, driven by strong demand from data center applications and successful export permit acquisition.
- Total revenue increased significantly to $28.0 million in Q3 2025 from $18.0 million in Q2 2025.
- GAAP gross margin saw a substantial recovery, rising to 22.3% in Q3 2025 from 8.0% in Q2 2025.
- GAAP net loss improved considerably, narrowing to $1.9 million in Q3 2025 from $7.0 million in Q2 2025.
- The company is building a healthy backlog for both indium phosphide and gallium arsenide materials.
- Management anticipates 'tremendous opportunity in 2026 to drive meaningful growth' and a 'return to profitability' due to ongoing market trends fueling the data center upgrade cycle.
Negatives
- The company reported a GAAP net loss of $1.9 million and a Non-GAAP net loss of $1.2 million for Q3 2025, indicating continued unprofitability.
- GAAP gross margin of 22.3% in Q3 2025 is lower than the 24.0% reported in Q3 2024.
- Year-to-date revenue for 2025 ($65.285 million) is lower than the same period in 2024 ($74.256 million).
- Year-to-date GAAP net loss for 2025 ($17.712 million) is significantly higher than the same period in 2024 ($6.536 million).
- Short-term loans increased to $61.547 million as of September 30, 2025, from $47.264 million at December 31, 2024.
Risks
- Requests for redemptions by private equity funds in China of investments in Tongmei.
- Administrative challenges in satisfying the requirements of various government agencies in China in connection with the listing of shares of Tongmei on the STAR Market.
- Continued open access to companies to list shares on the STAR Market.
- Investor enthusiasm for new listings of shares on the STAR Market.
- Geopolitical tensions between China and the United States.
- The timing and receipt of significant orders.
- The cancellation of orders and return of product.
- Emerging applications using chips or devices fabricated on our substrates.
- End-user acceptance of products containing chips or devices fabricated on our substrates.
- Our ability to bring new products to market.
- Product announcements by our competitors.
- The ability to control costs and improve efficiency.
- The ability to utilize our manufacturing capacity.
- Product yields and their impact on gross margins.
- The relocation of manufacturing lines and ramping of production.
- Possible factory shutdowns as a result of air pollution in China or COVID-19.
- COVID-19 or other outbreaks of a contagious disease.
- Tariffs and other trade war issues.
- The financial performance of our partially owned supply chain companies.
- Policies and regulations in China.
Future Outlook
Management believes there is a tremendous opportunity in 2026 to drive meaningful growth and a return to profitability, fueled by strong, ongoing market trends in the data center upgrade cycle. The company remains highly focused on gross margin recovery and expansion, operating expense discipline, and inventory reduction. They are also developing larger diameter substrates expected to enable the next generation of technology innovation across various end-markets.
Management Comments
- "This has been a highly active time for our business with the strong uptick in indium phosphide demand from data center applications globally."
- "In Q3, our indium phosphide revenues grew more than 250 percent sequentially and reached a three-year high as we obtained export permits for a number of significant indium phosphide orders throughout the quarter."
- "We continue to build healthy backlog for both indium phosphide and gallium arsenide materials as our industry and our customers adapt to a new normal within a rapidly changing environment."
- "We remain highly focused on our efforts to drive gross margin recovery and expansion, operating expense discipline, and inventory reduction."
- "With strong, ongoing market trends fueling the data center upgrade cycle, we believe we have tremendous opportunity in 2026 to drive meaningful growth in our business and a return to profitability."
Industry Context
The company's strong sequential performance is directly linked to a significant uptick in indium phosphide demand, particularly from global data center applications. This aligns with broader industry trends indicating a robust data center upgrade cycle, which drives demand for high-performance compound semiconductor wafer substrates like those manufactured by AXT. The adaptation of the industry and customers to a 'new normal' suggests ongoing shifts in supply chains and technology requirements.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks.
Stakeholder Impact
- Shareholders: Potential positive impact from improved financial performance, future growth prospects, and the eventual STAR Market listing of the subsidiary Tongmei.
- Customers: Benefit from increased availability of indium phosphide and gallium arsenide materials, and the development of larger diameter substrates for advanced devices.
- Employees: Continued focus on operational efficiency and growth could stabilize or expand employment opportunities.
Next Steps
- Continue efforts to drive gross margin recovery and expansion.
- Maintain operating expense discipline.
- Focus on inventory reduction.
- Advance the STAR Market IPO process for Tongmei, awaiting CSRC and other authorities' approval.
- Develop larger diameter substrates to enable next-generation technology innovation.
Key Dates
| Date | Description |
|---|---|
| January 10, 2022 | AXT announced its subsidiary, Tongmei, submitted its application for an IPO on the SSE's STAR Market. |
| July 12, 2022 | The Shanghai Stock Exchange (SSE) approved the listing of Tongmei's shares in an IPO on the STAR Market. |
| August 1, 2022 | The China Securities Regulatory Commission (CSRC) accepted Tongmei's IPO application for review. |
| September 30, 2025 | End of the third fiscal quarter for which financial results are reported. |
| October 30, 2025 | Date of the press release announcing Q3 2025 financial results and conference call. |
| November 6, 2025 | End date for conference call replay availability. |
Recommendation
holdThe company demonstrated strong sequential recovery in Q3 2025, driven by robust indium phosphide demand and improved operational metrics. The outlook for 2026 is positive with expectations of meaningful growth and a return to profitability. However, the company is still operating at a net loss, and year-to-date performance is weaker than the prior year. The STAR Market IPO for Tongmei, while a potential long-term catalyst, remains subject to regulatory approvals and is a lengthy process. Given the significant sequential improvement but ongoing challenges and uncertainties, a 'Hold' recommendation is appropriate, awaiting sustained profitability and clearer progress on the IPO.
Keywords
Compound semiconductor, wafer substrates, indium phosphide, gallium arsenide, germanium, data center connectivity, silicon photonics, 5G infrastructure, STAR Market IPO, financial results, earnings, AXTI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.